Fig. 3From: Exploring the therapeutic potential of isoorientin in the treatment of osteoporosis: a study using network pharmacology and experimental validationTarget-pathway network of ISO against OP and simulated molecular docking of ISO on AKT1, MAPK1. A Target-pathway network of ISO against OP. The color and size of each icon reflect the node degree for the common targets. B The most optimal simulated molecular docking of ISO on AKT1, MAPK1Back to article page